modafinil has been researched along with sodium oxybate in 48 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (2.08) | 18.2507 |
2000's | 17 (35.42) | 29.6817 |
2010's | 20 (41.67) | 24.3611 |
2020's | 10 (20.83) | 2.80 |
Authors | Studies |
---|---|
Hajdukovic, R; Mitler, MM | 1 |
Mignot, E | 1 |
Kilduff, TS; Wisor, JP | 1 |
Dauvilliers, Y; Tafti, M | 1 |
Black, J; Houghton, WC | 1 |
Bassetti, C; Billiard, M; Dauvilliers, Y; Dolenc-Groselj, L; Lammers, GJ; Mayer, G; Pollmächer, T; Reading, P; Sonka, K | 1 |
Thorpy, M | 1 |
Roth, T | 1 |
Arand, DL; Auger, RR; Brooks, SN; Watson, NF; Wise, MS | 1 |
Husain, AM; Peterson, PC | 1 |
Doghramji, PP; Gordon, ML; Lieberman, JA | 1 |
Akins, BE; Lacy, JM; Logan, BK; Miranda, E | 1 |
Mohsenin, V | 1 |
Guilleminault, C; Huang, YS | 1 |
Black, J; Hornfeldt, CS; Inhaber, N; Pardi, D | 1 |
Buckmaster, CL; Landolt, HP; Lyons, DM; Mignot, E; Zeitzer, JM | 1 |
Feldman, N; George, CF; Grzeschik, SM; Inhaber, N; Lai, C; Steininger, TL; Zheng, Y | 2 |
Hazin, R; Iqbal, M; Khan, F | 1 |
Buclin, T; Heinzer, RC; Rossetti, AO; Tafti, M | 1 |
Dimitriu, A; Guilleminault, C; Zaharna, M | 1 |
Ali, M; Auger, RR; Morgenthaler, TI; Slocumb, NL | 1 |
Crowe, C; Doherty, L; Sweeney, B | 1 |
Díaz, JR; López-Bernabé, R; Ortega-Albás, JJ; Serrano, AL | 1 |
Aran, A; Einen, M; Lin, L; Mignot, E; Nishino, S; Plazzi, G | 1 |
Quinnell, TG; Smith, IE | 1 |
Buckmaster, CL; Honda, Y; Kodama, T; Lyons, DM; Mignot, E; Nishino, S; Zeitzer, JM | 1 |
Santamaria-Cano, J | 1 |
Drakatos, P; Kent, BD; Leschziner, GD; Patel, K; Thakrar, C; Williams, AJ | 1 |
Black, J; Bogan, R; Carter, LP; Lai, C; Swick, T | 1 |
Dauvilliers, Y; Jennum, PJ; Knudsen, S; Kornum, BR; Ollila, HM; Overeem, S; Pizza, F | 1 |
Bassetti, CL; Kallweit, U | 1 |
Arango-Lopez, C; Canellas-Dols, F; Delgado, C; Peraita-Adrados, R | 1 |
Antelmi, E; Pizza, F; Plazzi, G; Vandi, S | 1 |
Alvarez-Horine, S; Black, J; Dauvilliers, Y; Dynin, E; Guinta, D; Roth, T | 1 |
Falissard, B; Lehert, P | 1 |
Kilduff, TS; Mayer, G; Peever, JH; Szabo, ST; Thorpy, MJ | 1 |
Arnulf, I; Dodet, P; Leu-Semenescu, S | 2 |
Bogan, RK; Thorpy, MJ | 1 |
Black, J; Bujanover, S; Husain, AM; Profant, J; Ryan, R; Scheckner, B | 1 |
de Biase, S; Gigli, GL; Pellitteri, G; Valente, M | 1 |
Chamula, K; Frenkel, S; Saini, B; Sivam, S; Swieca, J | 1 |
Baldin, E; Bassetti, CLA; Dauvilliers, Y; Dolenc-Groselj, L; Jennum, P; Kallweit, U; Khatami, R; Lammers, GJ; Lecendreux, M; Manconi, M; Mayer, G; Partinen, M; Plazzi, G; Pollmächer, T; Reading, P; Santamaria, J; Sonka, K; Vignatelli, L | 2 |
Berntsson, S; Boström, I; Fast, T; Gauffin, H; Komkova, A; Landtblom, AM | 1 |
Hashmi, SD; Kotagal, S; Maski, K; Robert Auger, R; Rowley, JA; Swick, TJ; Trotti, LM; Watson, NF | 1 |
Arnulf, I; Dauvilliers, Y; Roy, A; Thomas, R | 1 |
22 review(s) available for modafinil and sodium oxybate
Article | Year |
---|---|
An update on the pharmacotherapy of excessive daytime sleepiness and cataplexy.
Topics: Animals; Antidepressive Agents; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Clinical Trials as Topic; Disorders of Excessive Somnolence; Dogs; Humans; Modafinil; Narcolepsy; Sodium Oxybate; Treatment Outcome | 2004 |
Molecular genetic advances in sleep research and their relevance to sleep medicine.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Circadian Rhythm; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Disorders of Excessive Somnolence; Electroencephalography; Gene Expression; Humans; Intracellular Signaling Peptides and Proteins; Ion Channels; Mice; Modafinil; Molecular Biology; Neuropeptides; Orexins; Research; Serotonin; Signal Transduction; Sleep; Sodium Oxybate; Wakefulness | 2005 |
Molecular genetics and treatment of narcolepsy.
Topics: Animals; Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Catechol O-Methyltransferase; Central Nervous System Stimulants; Clomipramine; Genetic Predisposition to Disease; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Membrane Glycoproteins; Modafinil; Molecular Biology; Narcolepsy; Neuropeptides; Orexin Receptors; Orexins; Polymorphism, Genetic; Randomized Controlled Trials as Topic; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Sodium Oxybate | 2006 |
Therapeutic advances in narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Humans; Immunotherapy; Methylphenidate; Modafinil; Narcolepsy; Quality of Life; Selective Serotonin Reuptake Inhibitors; Selegiline; Sodium Oxybate | 2007 |
Treatment of narcolepsy and other hypersomnias of central origin.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Evidence-Based Medicine; Fluoxetine; Humans; Modafinil; Narcolepsy; Randomized Controlled Trials as Topic; Sodium Oxybate | 2007 |
Pediatric narcolepsy.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Child; Dextroamphetamine; Ghrelin; Hallucinations; Humans; Intracellular Signaling Peptides and Proteins; Leptin; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Randomized Controlled Trials as Topic; Sleep, REM; Sodium Oxybate | 2008 |
Stay awake! Understanding, diagnosing, and successfully managing narcolepsy.
Topics: Benzhydryl Compounds; Central Nervous System Stimulants; Female; Humans; Male; Modafinil; Narcolepsy; Polysomnography; Quality of Life; Sodium Oxybate | 2007 |
Narcolepsy: clinical decision making for the primary care physician.
Topics: Benzhydryl Compounds; Biomarkers; Cataplexy; Central Nervous System Stimulants; Decision Making; Diagnosis, Differential; Drug Approval; Hallucinations; Humans; Intracellular Signaling Peptides and Proteins; Life Style; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Physicians, Family; Polysomnography; Primary Health Care; Quality of Life; Respiration; Risk Factors; Sleep Paralysis; Sleep Stages; Sodium Oxybate; United States; United States Food and Drug Administration | 2009 |
Expert opinion on pharmacotherapy of narcolepsy.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Humans; Hypnotics and Sedatives; Immunotherapy; Intracellular Signaling Peptides and Proteins; Modafinil; Narcolepsy; Neuropeptides; Orexins; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate | 2010 |
[Diagnostic and therapeutic update in narcolepsy].
Topics: Adolescent; Adult; Age of Onset; Animals; Autoimmune Diseases; Benzhydryl Compounds; Cataplexy; Child; Clomipramine; Cyclohexanols; Delayed Diagnosis; Disease Models, Animal; Dogs; Genetic Predisposition to Disease; Histamine Agonists; HLA-DQ Antigens; HLA-DQ beta-Chains; Humans; Hypothalamus; Immunoglobulins, Intravenous; Intracellular Signaling Peptides and Proteins; Methylphenidate; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Receptors, Antigen, T-Cell; Sodium Oxybate; Venlafaxine Hydrochloride | 2012 |
Narcolepsy.
Topics: Adjuvants, Anesthesia; Benzhydryl Compounds; Biomarkers; Cataplexy; Genetic Predisposition to Disease; HLA-DQ beta-Chains; Humans; Modafinil; Narcolepsy; Orexins; Quality of Life; Risk Factors; Serotonin and Noradrenaline Reuptake Inhibitors; Sleep Wake Disorders; Sodium Oxybate; Wakefulness-Promoting Agents | 2017 |
Pharmacological management of narcolepsy with and without cataplexy.
Topics: Adult; Benzhydryl Compounds; Cataplexy; Drug Therapy, Combination; Humans; Modafinil; Narcolepsy; Neuropeptides; Off-Label Use; Orexins; Piperidines; Quality of Life; Sleep; Sodium Oxybate; Venlafaxine Hydrochloride; Wakefulness-Promoting Agents | 2017 |
Multiple treatment comparison in narcolepsy: a network meta-analysis.
Topics: Adult; Cataplexy; Humans; Modafinil; Narcolepsy; Network Meta-Analysis; Odds Ratio; Piperidines; Risk Assessment; Sleepiness; Sodium Oxybate | 2018 |
Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy.
Topics: Adjuvants, Anesthesia; Antidepressive Agents; Antidepressive Agents, Tricyclic; Cataplexy; Central Nervous System Stimulants; Drug Therapy; Humans; Immunogenetics; Intracellular Signaling Peptides and Proteins; Modafinil; Narcolepsy; Neurobiology; Sodium Oxybate | 2019 |
Precision Medicine for Idiopathic Hypersomnia.
Topics: Central Nervous System Stimulants; Clarithromycin; Flumazenil; GABA Modulators; Humans; Idiopathic Hypersomnia; Mazindol; Modafinil; Orexins; Piperidines; Polysomnography; Precision Medicine; Sleep; Sodium Oxybate; Wakefulness; Wakefulness-Promoting Agents | 2019 |
Update on the pharmacologic management of narcolepsy: mechanisms of action and clinical implications.
Topics: Adult; Cataplexy; Humans; Methylphenidate; Modafinil; Narcolepsy; Sodium Oxybate | 2020 |
Evaluating pitolisant as a narcolepsy treatment option.
Topics: Animals; Cataplexy; Humans; Modafinil; Narcolepsy; Piperidines; Sleep; Sodium Oxybate; Treatment Outcome | 2021 |
European guideline and expert statements on the management of narcolepsy in adults and children.
Topics: Adult; Cataplexy; Child; Humans; Modafinil; Narcolepsy; Sleep; Sodium Oxybate | 2021 |
European guideline and expert statements on the management of narcolepsy in adults and children.
Topics: Adult; Cataplexy; Child; Humans; Modafinil; Narcolepsy; Sleep; Sodium Oxybate | 2021 |
Treatment of central disorders of hypersomnolence: an American Academy of Sleep Medicine systematic review, meta-analysis, and GRADE assessment.
Topics: Adult; Child; Disorders of Excessive Somnolence; GRADE Approach; Humans; Modafinil; Sleep; Sodium Oxybate; United States | 2021 |
Precision Medicine for Idiopathic Hypersomnia.
Topics: Clarithromycin; Disorders of Excessive Somnolence; Female; Humans; Idiopathic Hypersomnia; Modafinil; Narcolepsy; Precision Medicine; Sodium Oxybate | 2022 |
Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion.
Topics: Disorders of Excessive Somnolence; Expert Testimony; Humans; Idiopathic Hypersomnia; Modafinil; Narcolepsy; Randomized Controlled Trials as Topic; Sleep; Sodium Oxybate | 2023 |
9 trial(s) available for modafinil and sodium oxybate
Article | Year |
---|---|
Relative efficacy of drugs for the treatment of sleepiness in narcolepsy.
Topics: Adult; Arousal; Benzhydryl Compounds; Central Nervous System Stimulants; Codeine; Dextroamphetamine; Female; Humans; Male; Methylphenidate; Modafinil; Narcolepsy; Pemoline; Piperidines; Protriptyline; Reaction Time; Ritanserin; Sleep Stages; Sodium Oxybate; Viloxazine; Wakefulness | 1991 |
Sodium oxybate improves excessive daytime sleepiness in narcolepsy.
Topics: Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Disorders of Excessive Somnolence; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Male; Modafinil; Narcolepsy; Polysomnography; Severity of Illness Index; Sodium Oxybate; Treatment Outcome; Wakefulness | 2006 |
Narcolepsy: action of two gamma-aminobutyric acid type B agonists, baclofen and sodium oxybate.
Topics: Adolescent; Baclofen; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Female; Follow-Up Studies; GABA Agonists; GABA-B Receptor Agonists; Humans; Male; Modafinil; Narcolepsy; Photoperiod; Polysomnography; Severity of Illness Index; Sleep; Sodium Oxybate; Time Factors | 2009 |
The nightly administration of sodium oxybate results in significant reduction in the nocturnal sleep disruption of patients with narcolepsy.
Topics: Adjuvants, Anesthesia; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Modafinil; Narcolepsy; Placebos; Polysomnography; Sleep; Sleep Wake Disorders; Sodium Oxybate; Wakefulness | 2009 |
A safety trial of sodium oxybate in patients with obstructive sleep apnea: Acute effects on sleep-disordered breathing.
Topics: Adjuvants, Anesthesia; Adult; Aged; Benzhydryl Compounds; Central Nervous System Stimulants; Comorbidity; Continuous Positive Airway Pressure; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Modafinil; Narcolepsy; Oxygen; Polysomnography; Product Surveillance, Postmarketing; Pyridines; Sleep Apnea, Obstructive; Sleep Stages; Sodium Oxybate; Zolpidem | 2010 |
A 2-week, polysomnographic, safety study of sodium oxybate in obstructive sleep apnea syndrome.
Topics: Adjuvants, Anesthesia; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Combined Modality Therapy; Continuous Positive Airway Pressure; Disorders of Excessive Somnolence; Drug Therapy, Combination; Female; Humans; Hypnotics and Sedatives; Male; Middle Aged; Modafinil; Polysomnography; Pyridines; Sleep Apnea, Obstructive; Sodium Oxybate; Zolpidem | 2011 |
Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
Topics: Adjuvants, Anesthesia; Adult; Benzhydryl Compounds; Cataplexy; Drug Therapy, Combination; Female; Humans; Male; Modafinil; Narcolepsy; Polysomnography; Retrospective Studies; Sodium Oxybate; Wakefulness; Wakefulness-Promoting Agents | 2016 |
Effect of sodium oxybate, modafinil, and their combination on disrupted nighttime sleep in narcolepsy.
Topics: Adult; Benzhydryl Compounds; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Modafinil; Narcolepsy; Polysomnography; Sleep Stages; Sodium Oxybate; Treatment Outcome | 2017 |
Incidence and duration of common, early-onset adverse events occurring during 2 randomized, placebo-controlled, phase 3 studies of sodium oxybate in participants with narcolepsy.
Topics: Adult; Disorders of Excessive Somnolence; Double-Blind Method; Humans; Incidence; Modafinil; Narcolepsy; Sodium Oxybate; Treatment Outcome | 2020 |
17 other study(ies) available for modafinil and sodium oxybate
Article | Year |
---|---|
EFNS guidelines on management of narcolepsy.
Topics: Advisory Committees; Antidepressive Agents; Benzhydryl Compounds; Catalepsy; Central Nervous System Stimulants; Disease Management; Europe; Humans; Modafinil; Narcolepsy; Sodium Oxybate | 2006 |
Narcolepsy: treatment issues.
Topics: Antidepressive Agents; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Circadian Rhythm; Combined Modality Therapy; Disorders of Excessive Somnolence; Dose-Response Relationship, Drug; Drug Approval; Health Education; Humans; Long-Term Care; Modafinil; Monoamine Oxidase Inhibitors; Narcolepsy; Psychotropic Drugs; Sodium Oxybate | 2007 |
A multi-drug intoxication fatality involving Xyrem (GHB).
Topics: Amines; Benzhydryl Compounds; Carisoprodol; Central Nervous System Depressants; Cetirizine; Cyclohexanecarboxylic Acids; Drug Interactions; Drug Therapy, Combination; Female; Forensic Toxicology; Gabapentin; gamma-Aminobutyric Acid; Gastrointestinal Contents; Humans; Middle Aged; Modafinil; Narcolepsy; Sleep Apnea Syndromes; Snoring; Sodium Oxybate; Tramadol; Vitreous Body | 2009 |
Narcolepsy--master of disguise: evidence-based recommendations for management.
Topics: Adjuvants, Anesthesia; Attention Deficit and Disruptive Behavior Disorders; Benzhydryl Compounds; Catalepsy; Central Nervous System Stimulants; Diagnosis, Differential; Drug Therapy, Combination; Evidence-Based Medicine; Follow-Up Studies; Humans; Male; Middle Aged; Modafinil; Narcolepsy; Polysomnography; Sleep, REM; Sodium Oxybate | 2009 |
Modafinil and γ-hydroxybutyrate have sleep state-specific pharmacological actions on hypocretin-1 physiology in a primate model of human sleep.
Topics: Animals; Benzhydryl Compounds; Central Nervous System Stimulants; Humans; Hydrocortisone; Intracellular Signaling Peptides and Proteins; Male; Modafinil; Models, Animal; Neuropeptides; Orexins; Saimiri; Sleep; Sodium Oxybate; Wakefulness | 2009 |
Rapid occurrence of depression following addition of sodium oxybate to modafinil.
Topics: Adjuvants, Anesthesia; Adult; Benzhydryl Compounds; Central Nervous System Stimulants; Depression; Drug Interactions; Humans; Male; Modafinil; Narcolepsy; Sodium Oxybate | 2010 |
Idiopathic hypersomnia: clinical features and response to treatment.
Topics: Actigraphy; Adult; Benzhydryl Compounds; Caffeine; Central Nervous System Stimulants; Dextroamphetamine; Female; Follow-Up Studies; Humans; Idiopathic Hypersomnia; Male; Methamphetamine; Methylphenidate; Modafinil; Pemoline; Polysomnography; Retrospective Studies; Sodium Oxybate; Treatment Outcome | 2009 |
National narcolepsy survey.
Topics: Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Health Surveys; Humans; Intracellular Signaling Peptides and Proteins; Ireland; Modafinil; Narcolepsy; Neuropeptides; Orexins; Polysomnography; Prevalence; Sodium Oxybate | 2010 |
Sodium oxybate and modafinil: a good combination?
Topics: Benzhydryl Compounds; Drug Interactions; Drug Therapy, Combination; Humans; Hypnotics and Sedatives; Mental Disorders; Modafinil; Sleep Wake Disorders; Sodium Oxybate | 2010 |
Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children.
Topics: Adjuvants, Anesthesia; Adolescent; Age Distribution; Age of Onset; Antidepressive Agents, Second-Generation; Benzhydryl Compounds; Central Nervous System Stimulants; Child; Cyclohexanols; Drosophila Proteins; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Modafinil; Narcolepsy; Nerve Tissue Proteins; Nuclear Proteins; Overweight; Polysomnography; Puberty; Retrospective Studies; Sodium Oxybate; Streptococcal Infections; Surveys and Questionnaires; Transcription Factors; United States; Venlafaxine Hydrochloride; Weight Gain | 2010 |
Narcolepsy, idiopathic hypersomnolence and related conditions.
Topics: Antidepressive Agents, Tricyclic; Benzhydryl Compounds; Catalepsy; Central Nervous System Stimulants; Dextroamphetamine; Humans; Hypnotics and Sedatives; Idiopathic Hypersomnia; Life Style; Methylphenidate; Modafinil; Narcolepsy; Polysomnography; Selective Serotonin Reuptake Inhibitors; Sodium Oxybate; Treatment Outcome | 2011 |
Time-course of cerebrospinal fluid histamine in the wake-consolidated squirrel monkey.
Topics: Animals; Benzhydryl Compounds; Circadian Rhythm; Female; Histamine; Hydrocortisone; Locomotion; Modafinil; Saimiri; Sleep; Sodium Oxybate; Time Factors; Wakefulness | 2012 |
Sleep-stage sequencing of sleep-onset REM periods in MSLT predicts treatment response in patients with narcolepsy.
Topics: Adult; Benzhydryl Compounds; Cataplexy; Central Nervous System Stimulants; Female; Humans; Male; Modafinil; Narcolepsy; Polysomnography; Prognosis; Retrospective Studies; Sleep, REM; Sodium Oxybate | 2016 |
Narcolepsy-cataplexy and psychosis: a case study.
Topics: Adolescent; Antipsychotic Agents; Attention Deficit Disorder with Hyperactivity; Benzhydryl Compounds; Female; Food Addiction; Hallucinations; Haloperidol; HLA-DQ beta-Chains; Humans; Learning Disabilities; Methylphenidate; Modafinil; Narcolepsy; Orexins; Pediatric Obesity; Polysomnography; Psychotic Disorders; Risperidone; Sleep Deprivation; Sleep Latency; Social Isolation; Sodium Oxybate; Suicidal Ideation | 2017 |
Stereotyped episodes of aphasia and immobility: how cataplexy mimics stroke in an elderly patient.
Topics: Adjuvants, Anesthesia; Age of Onset; Aphasia; Cataplexy; Diagnostic Errors; Electroencephalography; Humans; Male; Middle Aged; Modafinil; Movement Disorders; Sodium Oxybate; Stroke; Wakefulness-Promoting Agents | 2017 |
Narcolepsy management in Australia: time to wake up.
Topics: Australia; Dextroamphetamine; Drug Costs; Health Expenditures; Health Services Accessibility; Humans; Methylphenidate; Modafinil; Narcolepsy; Polysomnography; Practice Guidelines as Topic; Prevalence; Randomized Controlled Trials as Topic; Sodium Oxybate; Treatment Outcome; Wakefulness-Promoting Agents | 2021 |
Narcolepsy treatment in Sweden: An observational study.
Topics: Antidepressive Agents; Female; Humans; Male; Modafinil; Narcolepsy; Sodium Oxybate; Sweden | 2022 |